Sydney, Nov 3, 2017 AEST (ABN Newswire) - Anatara Lifesciences (ASX:ANR) CSO, Dr Tracey Mynott, was recently invited to present at the Translational Research Institute's (TRI) Science Business Inspiration Series. The series was launched with Session 1 "The whole journey: from idea to reality". Through her presentation, Tracey shared her personal journey - translating core research about pineapple roots and piglet gut health - to her current status as CSO of a publicly listed company, which is intent on changing the livestock industry globally.

To read more, please visit:
http://www.abnnewswire.net/lnk/713SA081


About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies. Please see http://www.anataralifesciences.com for further background.

    


Contact

Investor inquiries:
Dr Mel Bridges
Chairman & CEO
Anatara Lifesciences
Phone: +61-413-051-600
Email: mbridges@anataralifesciences.com

Media inquiries:
Jane Lowe
IR Department
Phone: +61-411-117-774
Email: jane.lowe@irdepartment.com.au


Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 184) (Last 30 Days: 956) 
ANALYTICS: LOGIN HERE

Anatara Lifesciences Ltd NEWS: RECENT VISITS (5370)

Research Report

Social Media